Phenotyping established chronic lung allograft dysfunction predicts extracorporeal photopheresis response in lung transplant patients

American Journal of Transplantation

Volumn 13, Issue 4, 2013, Pages 911-918

  Greer, M ^a   Dierich, M ^a   De Wall, C ^a   Suhling, H ^a   Rademacher, J ^a   Welte, T ^a   Haverich, A ^a   Warnecke, G ^a   Ivanyi, P ^a   Buchholz, S ^a   Gottlieb, J ^a   Fuehner, T ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Bronchiolitis obliterans syndrome; chronic allograft dysfunction; extracorporeal photopheresis; lung transplantation

Indexed keywords

AZITHROMYCIN;

ADULT; ARTICLE; CHRONIC LUNG ALLOGRAFT DYSFUNCTION; EXTRACORPOREAL OXYGENATION; EXTRACORPOREAL PHOTOPHERESIS; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; GRAFT DYSFUNCTION; GRAFT FAILURE; HUMAN; LUNG LAVAGE; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NEUTROPHILIA; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; PUVA; RESTRICTIVE ALLOGRAFT SYNDROME; RETROSPECTIVE STUDY; TREATMENT RESPONSE;

ADULT; ALGORITHMS; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; BRONCHIOLITIS OBLITERANS; BRONCHOALVEOLAR LAVAGE; DISEASE-FREE SURVIVAL; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LIGHT; LUNG; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; NEUTROPHILS; PHENOTYPE; PHOTOPHERESIS; PRIMARY GRAFT DYSFUNCTION; RETROSPECTIVE STUDIES; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 84875723226     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12155     Document Type: Article

References (46)

1. Christie J, Edwards L, Kucheryavaya BC, et al. The registry of the international society for heart and lung transplantation: Twenty-eighth adult lung and heart-lung transplant report-2011. J Heart Lung Transplantat 2011; 30: 1104-1123.
2. Estenne M, Maurer J, Boehler A, et al. Bronchiolitis obliterans syndrome 2001: An update of the diagnostic criteria. J Heart Lung Transplant 2002; 21: 297-310. (Pubitemid 34224094)
3. Sato M, Waddell T, Wagnetz U, et al. Restrictive allograft syndrome (RAS): A novel form of chronic lung allograft dysfunction. J Heart Lung Transplant 2011; 30: 735-43.
4. Hayes D,. A Review of bronchiolitis obliterans syndrome and therapeutic strategies. Journal of Cardiothoracic Surgery 2011; 18; 6: 92.
5. Verleden G, Vos R, Verleden S, et al. Survival determinants in lung transplantation patients with chronic allograft dysfunction. Transplantation 2011; 92: 703-708.
6. Estenne M, Hertz M,. Bronchiolitis obliterans after human lung transplantation. Am J Resp Crit Care Med 2002; 166: 440-444.
7. Cooper J, Billingham M, Egan T, et al. A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. International Society for Heart and Lung Transplantation. J Heart Lung Transplant 1993; 12: 713-716. (Pubitemid 23305066)
8. Jackson C, Sharples L, McNeil K, Stewart S, Wallwork J,. Acute and chronic onset of bronchiolitis obliterans syndrome (BOS): Are they different entities? J Heart Lung Transplant 2002; 21: 658-666. (Pubitemid 34626359)
9. Knoop C, Estenne M,. Acute and chronic rejection after lung transplantation. Semin Resp Crit Care Med 2006; 27: 521-533. (Pubitemid 44672555)
10. 1 after onset of bronchiolitis obliterans syndrome in lung transplant recipients. Am J Resp Crit Care Med 2007; 175: 1192-1198. (Pubitemid 46855462)
11. Verleden G, Dupont L,. Azithromycin therapy for patients with bronchiolitis obliterans syndrome after lung transplantation. Transplantation 2004; 77: 1465-1467. (Pubitemid 38668447)
12. Gottlieb J, Szangolies J, Koehnlein T, Golpon H, Simon A, Welte T,. Long-term azithromycin for bronchiolitis obliterans syndrome after lung transplantation. Transplantation 2008; 85: 36-41.
13. Yates B, Murphy D, Forrest I, et al. Azithromycin reverses airflow obstruction in established bronchiolitis obliterans syndrome. Am J Resp Crit Care Med 2005; 172: 772-775. (Pubitemid 41324235)
14. Neurohr C, Huppmann P, Samweber B, et al. Prognostic value of bronchoalveolar lavage neutrophillia in stable lung transplant recipients. J Heart Lung Transplant 2009; 28: 468-474.
15. Verleden S, Vos R, Mertens V, et al. Heterogeneity of chronic lung allograft dysfunction: Insights from protein expression in bronchoalveolar lavage. J Heart Lung Transplant 2011; 30: 667-673.
16. Vos R, Vanaudenaerde B, Verleden S, et al. A randomised controlled trail of azithromycin to prevent chronic rejection after lung transplantation. Eur Respir J 2011; 37: 164-172.
17. Verleden G, Verleden S, Vos R, et al. Montelukast for bronchiolitis obliterans syndrome after lung transplantation: A pilot study. Transplantat Int 2011; 24: 651-656.
18. Todd J, Palmer S,. Bronchiolitis obliterans syndrome-The final frontier for lung transplantation. Chest 2011; 140: 502-508.
19. Zuo X, Matsumura Y, Prehn J,. Cytokine gene expression in rejecting and tolerant rat lung allograft models: Analysis by RT-PCR. Transpl Immunol 1995; 3: 151-161.
20. Jaramillo A, Fernandez F, Kuo E, Trulock E, Patterson G, Mohanakumar T,. Immune mechanisms in the pathogenesis of bronchiolitis obliterans syndrome after lung transplantation. Pediatr Transplant 2005; 9: 84-93. (Pubitemid 40238970)
21. Mauck K, Hosenpud J,. The bronchial epithelium: A potential allogeneic target for chronic rejection after lung transplantation. J Heart Lung Transplant 1996; 15: 709-714. (Pubitemid 26268890)
22. Morrell M, Despotis G, Lublin D, Patterson G, Trulock E, Hachem R,. The efficacy of photophoresis for bronchiolitis obliterans syndrome after lung transplantation. J Heart Lung Transplant 2010; 29: 424-431.
23. Rook A, Cohen J,. Therapeutic applications of photopheresis. Derm Clin 1993; 11: 339-347. (Pubitemid 23135727)
24. Andreu G, Achkar A, Couetil J,. Extracorporeal photochemotherapy treatment for acute lung rejection episode. J Heart Lung Transplant 1995; 14: 793-796.
25. Meloni F, Cascina A, Miserere S, Perotti C, Vitulo P, AM F. Peripheral CD4 + CD25 +TREG cell counts and the respone to extracorporeal photopheresis in lung transplant recipients. Transplant Proc 2007; 39: 213-217. (Pubitemid 46175985)
26. Benden C, Speich R, Hofbauer G,. Extracorporeal photopheresis after lung transplantation: A 10-year single center experience. Transplantation 2008; 86: 1625-1627.
27. O'Hagan A, Stillwell P, Arroliga A, Koo A,. Photopheresis in the treatment of refractory bronchiolitis obliterans complicating lung transplantation. Chest 1999; 115: 1459-1462. (Pubitemid 29230666)
28. Salerno C, Park S, Kreykes N,. Adjuvant treatment of refractory lung transplant rejection with extracorporeal photopheresis. J Thoracic Cardiovasc Surg 1999; 117: 1063-1069. (Pubitemid 29270344)
29. Marques M, Schwartz J,. Update on extracorporeal photopheresis in heart and lung transplantation. J Clin Apheresis 2011; 26: 146-151.
30. Szczepiorkowski Z, Bandarenko N, Kim H,. Guidelines on the use of therapeutic apheresis in clinical practice: Evidence-based approach from the Apheresis applications committee of the American Society Apheresis. J Clin Apher 2007; 14: 106-175. (Pubitemid 47025120)
31. Miller M, Hankinson J, Brusasco V,. Standardisation of spirometry. Eur Respir J 2005; 26: 319-328.
32. George J, Gooden C, Guo W, Kirklin J,. Role for CD4 CD25 T cells in inhibition of graft rejection by extracorporeal photopheresis. J Heart Lung Transplant 2008; 27: 616-622. (Pubitemid 351707621)
33. Finlen Copeland C, Snyder L, Zaas D, Turbyfill W, Davis W, Palmer S,. Survival after bronchiolitis obliterans syndrome among bilateral lung transplant recipients. Am J Respir Crit Care Med 2010; 182: 784-789.
34. Morelli A, Larregina A,. Apoptotic cell-based therapies against transplant rejection: Role of recipient's dendritic cells. Apoptosis 2010; 15: 1083-1097.
35. Hivelin M, Siemionow M, Grimbert P, Lantieri L,. Extracorporeal photopheresis: From solid organs to face transplantation. Transpl Immunol 2009; 21: 117-128.
36. Meloni F, Vitulo P, Bianco A, et al. Regulatory CD4+CD25+ T-Cells in the peripheral blood of lung transplant recipients: Correlation with transplant outcome. Transplantation 2003; 77: 762-766. (Pubitemid 38366987)
37. Najarian J, Ferguson R, Sutherland D,. Fractionated total lymphoid irradiation as preparative immunosuppression in high-risk renal transplantation. Ann Surg 1982; 196: 442-452. (Pubitemid 12030721)
38. Salter M, Kirklin J, Bourge R,. Total lymphoid irradiation in the treatment of early or recurrent heart rejection. J Heart Lung Transplant 1992; 11: 902-912.
39. Diamond D, Michalski J, Lynch J, Trulock E,. Efficacy of total lymphoid irradiation for chronic allograft rejection following bilateral lung transplantation. Int J Radiation Oncology Biol Phys 1998; 41: 795-800. (Pubitemid 28285956)
40. Fisher A, Rutherford R, Bozzino J, Parry G, Dark J, Corris P,. The safety and efficacy of total lymphoid irradiation in progressive bronchiolitis obliterans syndrome after lung transplantation. Am J Transplant 2005; 5: 537-543. (Pubitemid 40313345)
41. Verleden G, Lievens Y, Dupont L, et al. Efficacy of total lymphoid irradiation in azithromycin nonresponsive chronic allograft rejection after lung transplantation. Transplant Proc 2009; 41: 1816-1820.
42. Villanueva J, Bhorade S, Robinson J, Husain A, Garrity E,. Extracorporeal photopheresis for the treatment of lung allograft rejection. Ann Transplant 2000; 5: 44-47.
43. Meloni F, Solari N, Morosini M, et al. Clinical and immunological evaluation of 12-month azithromycin therapy in chronic lung allograft rejection. Clin Transplantat 2011; 25: E381-E389.
44. Jaksch P, Scheed A, Keplinger M, et al. A prospective interventional study on the use of extracorporeal photopheresis in patients with bronchiolitis obliterans syndrome after lung transplantation. J Heart Lung Transplant 2012; 31: 950-957.
45. Vos R, Vanaudnaerde BM, Verleden SE, et al. Bronchoalveolar lavage neutrophilia in acute lung allograft rejection and lymphocytic bronchiolitis. J Heart Lung Transplant 2010; 29: 1259-1269.
46. Glanville A, Aboyoun C, Havryk A, Plit M, Rainer S, Malouf M,. Severity of lymphocytic bronchiolitis predicts long-term outcome after lung transplantation. Am J Respir Crit Care Med 2008; 177: 1033-1040. (Pubitemid 351717599)